Icon

BENDEKA (nda208194)- (100MG/4ML (25MG/ML))

BENDAMUSTINE HYDROCHLORIDE EAGLE PHARMS
100MG/4ML (25MG/ML)
Yes Yes
2033-Mar-15 Expired
None None
None No
Bendamustine hydrochloride is an alkylating drug indicated for treatment of patients with: • Chronic lymphocytic leukemia (CLL). • Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
0 3 0
Total Other Developers 10
Drugs with Suitability No
100MG/4ML (25MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.